A team led by scientists at Scripps Research has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.
Jul 13, 2020
1
6208
A team led by Scripps Research has discovered antibodies in the blood of recovered COVID-19 patients that provide powerful protection against SARS-CoV-2, the coronavirus that causes the disease, when tested in animals and ...
Jun 15, 2020
1
2015
The Moderna COVID-19 vaccine, which the company says was recently demonstrated to have 94 percent efficacy, causes the human immune system to produce potent antibodies that endure for at least three months, a study showed ...
Dec 3, 2020
0
742
According to new research, people who have had COVID enjoy strong immunity against the coronavirus for at least a year after they were initially infected. In analyzing antibodies present in the blood of COVID patients, Rockefeller ...
May 31, 2021
0
35
Exceptionally potent antibodies that can neutralize virtually all known variants of the COVID-19 virus—including omicron, as well as other dangerous animal coronaviruses that could potentially cause future outbreaks—have ...
Jul 28, 2023
0
338
A type of immunotherapy that has shown promising results against cancer could also be used against HIV, the virus that causes AIDS.
Jul 15, 2016
1
103
Tick-borne encephalitis is a disease just as nasty as it sounds. Once bitten by an infected tick, some people develop flu-like symptoms that resolve quietly but leave behind rampant neurological disease—brain swelling, ...
Apr 9, 2021
0
255
The original vaccinations for COVID-19 induce potent antibodies that protect against SARS-CoV-2.
Feb 15, 2023
1
137
Last year, scientists at Scripps Research and Toscana Life Sciences studied the blood of 14 COVID-19 survivors to find the most potent antibodies against the SARS-CoV-2 virus. One of the leading molecules that emerged—now ...
May 13, 2022
1
219
A discovery about how the immune system responds to malaria infection could lead to better treatments for hepatitis C, HIV and lupus, say Australian researchers.
Nov 19, 2019
0
818
